Dr. Rachit Kumar, MD

Dr. Kumar practices at Virginia Cancer Institute Incorporated in Richmond, Virginia.

Dr. Kumar's NPI, 1316258148, was assigned on June 25, 2010. Dr. Kumar holds Maine license 21381.

Dr. Kumar's primary practice is Virginia Cancer Institute Incorporated, at 7202 Glen Forest Dr, Richmond, VA 23226 in Henrico County. The practice phone is (804) 287-3000.

Dr. Kumar's primary practice is Virginia Cancer Institute Incorporated in Richmond, Virginia. Dr. Kumar is also affiliated with Bon Secours St. Mary's Hospital. The medical group on file is Virginia Cancer Institute. Dmand AI also links Dr. Kumar to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kumar practices, 5 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Kumar's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Kumar is licensed in Maine.

CMS data shows 60,274 Medicare services from Dr. Kumar across 52 procedure codes in 2024, for 780 Medicare patients. Medicare paid $1,652,703 for them.

CMS counts 780 Medicare patients who saw Dr. Kumar in 2024. The largest group is 75 to 84, with 324 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 5% are also on Medicaid. Their average risk score is 1.97, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kumar's median patient age at 66, with 60% women.

In 2024, Dr. Kumar wrote 923 Medicare Part D claims for 166 patients. 75% of them were for generic drugs. CMS names the drug for 646 of them, across 23 drugs with 11 or more claims each, at $1,297,535 in total drug cost. In 2023, CMS named 538 claims across 22 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Kumar for performance year 2024, reported as part of a group. Dr. Kumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kumar as offering telehealth.

Dmand AI links 64 papers to Dr. Kumar, published from 2011 to 2025. 2022 was the busiest year, with 8. The most frequent topics are Pancreatic Neoplasms, Adenocarcinoma and Radiotherapy Planning, Computer-Assisted. Dr. Kumar has published most often in Int J Radiat Oncol Biol Phys. Dr. Kumar's most frequent co-authors are Christopher James Anker, MD, Joseph M. Herman, MD and Percy Po-Yih Lee, MD.

CMS Open Payments shows 293 general payments to Dr. Kumar from 61 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 50% of the total. Ipsen Biopharmaceuticals, Inc paid the most, $6,671.